<!DOCTYPE HTML>
<html lang="en">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Shahmir Aziz</title>

    <meta name="author" content="Shahmir Aziz">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="shortcut icon" href="images/headshot.png" type="image/x-icon">
    <link rel="stylesheet" type="text/css" href="stylesheet.css">
  </head>

  <body>
    <table style="width:100%;max-width:800px;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
      <tr style="padding:0px">
        <td style="padding:0px">
          <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
            <tr style="padding:0px">
              <td style="padding:2.5%;width:63%;vertical-align:top">
                <p class="name" style="text-align: left;">
                  Shahmir Aziz
                </p>

                <p class="bio">
                  I am a Rhodes Scholar DPhil student at Oxford's <a href="https://www.kavli.ox.ac.uk">Kavli Institute for Nanoscience Discovery</a>,
                  working with <a href="https://www.bioch.ox.ac.uk/research/robinson">Dr. Dame Carol Robinson</a> on machine learning for nanoscale robotics.
                </p>

                <p class="bio">
                  Previously, I graduated from Harvard AB Summa Cum Laude in Mathematics and Biomedical Engineering with a minor in Computer Science.
                  I was awarded the John Harvard Scholar designation and the Detur Prize, the oldest academic prize at Harvard.
                </p>

                <p class="bio">
                  I've done quantitative research at Citi's rates trading desk,
                  biological systems optimization at Novo Nordisk, and co-founded SAR Capital Management,
                  an intercollegiate hedge fund focused on biotech equities where I lead quantitative research.
                </p>

                <p class="bio">
                  My research interests lie at the intersection of machine learning and nanoscale robotics,
                  particularly in developing ML algorithms for controlling swarm behavior at the molecular level,
                  optimizing targeted drug delivery systems, and creating autonomous nanoscale surgical tools.
                </p>

                <p style="text-align:left; margin-top: 20px;">
                  <a href="mailto:shahmiraziz@college.harvard.edu">Email</a> &nbsp;/&nbsp;
                  <a href="https://www.linkedin.com/in/shahmiraziz/">LinkedIn</a>
                </p>
              </td>
              <td style="padding:2.5%;width:37%;max-width:37%;vertical-align:top">
                <a href="images/headshot.png"><img style="width:100%;max-width:100%;object-fit: cover; border-radius: 50%;" alt="profile photo" src="images/headshot.png" class="hoverZoomLink"></a>
              </td>
            </tr>
          </tbody></table>


    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Publications</h2></td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/publication.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <p> <a href="shahmir_thesis.pdf">Engineering Asymmetry: Geometric Design of Nanoscale Lipid Vesicles for Uptake-Optimized Drug Delivery</a><br>
          <em><strong>Harvard Senior Thesis</strong></em></p>
        <p><strong>Shahmir Aziz</strong>, advised by Prof. David Weitz<br>
          <em>Harvard Thesis Collection</em>, 2025<br>
          <a href="shahmir_thesis.pdf">paper</a></p>
        <p>Developing asymmetric nanoscale lipid vesicles with optimized geometries for enhanced cellular uptake and targeted drug delivery applications.</p>
      </td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Blog Posts</h2></td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/blog1.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <a href="blog1.html">
          <span class="papertitle">Engineering Log: Stochastic Gradient Descent for Molecular Swarm Control</span>
        </a>
        <br>
        <em>Week 14 - December 2024</em>
        <br>
        <p>85% complete. RL approach for 10^4 particle swarm control. Current bottleneck: gradient explosion at t>1000. Real-world success: 71% (up from 61%). Targeting animal trials Week 17.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:16px;width:20%;vertical-align:middle">
        <div class="one">
          <img src="images/blog2.png" width="100%">
        </div>
      </td>
      <td style="padding:8px;width:80%;vertical-align:middle">
        <a href="blog2.html">
          <span class="papertitle">Research Notes: Transformer Networks for Protein-Nanoparticle Binding</span>
        </a>
        <br>
        <em>Week 11 - November 2024</em>
        <br>
        <p>RÂ²=0.79 but fails on glycosylated proteins. 14ms inference vs 48hr simulations. Working on uncertainty quantification. Code too messy to release yet.</p>
      </td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
        <td style="padding:16px;width:20%;vertical-align:middle"><h2>Experience</h2></td>
    </tr>
    </tbody></table>

    <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Co-Founder</strong> - SAR Capital Management</p>
        <p class="experience-date">November 2023 - Present</p>
        <p>Co-founded intercollegiate hedge fund focused on biotech and pharmaceutical companies. Implement long-only trading strategies with quantitative and scientific reasoning. Head the Quantitative research wing.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Mathematics Teaching Fellow</strong> - Harvard University</p>
        <p class="experience-date">August 2022 - Present</p>
        <p>Tutored students in Math courses on multivariable calculus and linear algebra. Worked with professors to employ interactive teaching methods.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Quant Trading / Research Intern</strong> - Citi</p>
        <p class="experience-date">May 2024 - August 2024</p>
        <p>Developed and refined trading strategies for rates products. Worked directly with senior traders to implement strategies and analyze profitability.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Biological Systems Analyst</strong> - Novo Nordisk</p>
        <p class="experience-date">May 2023 - August 2023</p>
        <p>Focused on predictive optimization of processes in drug production, using inferential statistics. Analysis of macro datasets of drug quality vs production speed.</p>
      </td>
    </tr>
    <tr>
      <td style="padding:8px;width:100%;vertical-align:middle">
        <p class="experience-title"><strong>Executive Board - Chief Auditor</strong> - Harvard International Relations Council</p>
        <p class="experience-date">April 2022 - June 2023</p>
        <p>In charge of $1M budget of Harvard's largest student-run organization. Head finances and executive dealings of umbrella organization presiding over all International Relations-affiliated groups on campus.</p>
      </td>
    </tr>
    </tbody></table>

          <table style="width:100%;border:0px;border-spacing:0px;border-collapse:separate;margin-right:auto;margin-left:auto;"><tbody>
            <tr>
              <td style="padding:0px">
                <br>
                <p style="text-align:right;font-size:small;">

                </p>
              </td>
            </tr>
          </tbody></table>
        </td>
      </tr>
    </table>

  </body>
</html>